Dr. Michael Lagios is an expert pathologist from San Franciso, California. He has an extensive medical experience of more than 40 years. He is specialized in anatomic pathology and clinical pathology. Dr. Lagios graduated in 1965 from the medical school of the University of California San Francisco. He continued with an internship at the University of Southern California - LAC+USC Medical Center and completed a residency stage at the University of California San Francisco. He is a board-certified pathologist. Dr. Lagios has also been involved in the research area where he contributed to several publications. Some of his studies focused on ductal carcinoma in situ of the breast and areas of controversy in ductal carcinoma. At the moment, Dr. Michael Lagios practices medicine at St. Mary's Hospital.
University of California San Francisco
Medical School
University of Southern California - LAC+USC Medical Center
Dr. Michael Lagios has contributed to 2 publications.
Treatment Selection for Patients with Ductal Carcinoma In Situ (DCIS) of the Breast Using the University of Southern California/Van Nuys (USC/VNPI) Prognostic Index.
Silverstein, M. J.,Lagios, M. D.; Breast J. 2015 Jan 21.
Dr. Michael Lagios is an expert pathologist from San Franciso, California. He has an extensive medical experience of more than 40 years. He is specialized in anatomic pathology and clinical pathology. Dr. Lagios graduated in 1965 from the medical school of the University of California San Francisco. He continued with an internship at the University of Southern California - LAC+USC Medical Center and completed a residency stage at the University of California San Francisco. He is a board-certified pathologist. Dr. Lagios has also been involved in the research area where he contributed to several publications. Some of his studies focused on ductal carcinoma in situ of the breast and areas of controversy in ductal carcinoma. At the moment, Dr. Michael Lagios practices medicine at St. Mary's Hospital.
Dr. Michael Lagios has contributed to 2 publications.
Treatment Selection for Patients with Ductal Carcinoma In Situ (DCIS) of the Breast Using the University of Southern California/Van Nuys (USC/VNPI) Prognostic Index.
Silverstein, M. J.,Lagios, M. D.; Breast J. 2015 Jan 21.
Hospitals & Clinics
specialties & services
